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Background. Blackwater fever (BWF), one of the complications of severe malaria, has recently re-emerged as a cause of severe 
anemia (SA) in African children. However, postdischarge morbidity in children with BWF has previously not been described.
Methods. This was a descriptive cohort study in which children, aged 0–5 years, admitted to Jinja Regional Referral Hospital 
with acute episodes of SA (hemoglobin ≤5.0 g/dL) were followed up for 6 months after hospitalization. Incidence of readmissions or 
deaths during the follow-up period was compared between SA children with BWF and those without BWF.
Results. A total of 279 children with SA including those with BWF (n = 92) and no BWF (n = 187) were followed for the du-
ration of the study. Overall, 128 (45.9%) of the study participants were readmitted at least once while 22 (7.9%) died during the 
follow-up period. After adjusting for age, sex, nutritional status, and parasitemia, SA children with BWF had higher risk of readmis-
sions (hazard ratio [HR], 1.68; 95% confidence interval [CI], 1.1–2.5) and a greater risk of death (HR. 3.37; 95% CI, 1.3–8.5) com-
pared with those without BWF. Malaria and recurrence of SA were the most common reasons for readmissions.
Conclusions. There is a high rate of readmissions and deaths in the immediate 6 months after initial hospitalization among SA 
children in the Jinja hospital. SA children with BWF had increased risk of readmissions and deaths in the postdischarge period. 
Postdischarge malaria chemoprophylaxis should be considered for SA children living in malaria endemic areas.
Keywords.  blackwater fever; severe anemia; postdischarge; mortality.
Severe anemia (SA) (hemoglobin [Hb]  <5  g/dL) remains a 
public health problem in resource-limited settings, accounting 
for up to 9.7–29% of all pediatric admissions and 8–17% of 
inpatient deaths [1–4]. Plasmodium falciparum malaria is the 
cause of a severe clinical spectrum of malaria, including SA, in 
malaria-endemic areas [5, 6]. Several studies have shown that 
severe malarial anemia is associated with significant morbidity 
in the immediate postdischarge period [7–9].
Although the cause of SA is multifactorial, malaria infection 
remains the main driving factor for the high prevalence of SA 
in sub-Saharan Africa [10, 11]. One manifestation of malaria 
associated with SA is blackwater fever (BWF), a resurgence of 
which has recently been reported in parts of East Africa [12]. 
Blackwater fever is a massive intravascular hemolytic event that 
is thought to be triggered by malaria infection [13] and use 
of antimalarials such as quinine [14, 15], mefloquine [16, 17], 
artemisinins [12], halofantrine [16–18], and/or lumefantrine, 
which is a second component of artemisinin-based combina-
tion therapies [19]. There is a paucity of data on the etiology of 
BWF in Ugandan children. This cryptic disease typically pre-
sents clinically with SA associated with episodes of passage of 
dark or tea-colored urine [13]. In eastern Uganda, BWF was 
reported in 14.5% and 21.8%, respectively, of sick children pre-
senting to 2 regional referral hospitals [20]. The few studies on 
BWF have mainly been hospital based with limited information 
on the postdischarge outcomes [21–23]. It is not clear whether 
the postdischarge morbidity of SA associated with BWF and 
other nonmalarial etiologies is similar to that previously re-
ported. Hence, there are presently no specific guidelines for 
postdischarge management of SA, even for that associated with 
malaria. To inform further studies on postdischarge SA there is 
a need to establish the postdischarge outcomes of SA in areas 
where the burden of BWF is high.
We followed up a cohort of children aged 0–5 years admitted 
with SA to a tertiary hospital in Uganda. Our aim was to com-
pare the frequency and risk of readmissions and death among 
children with SA complicated by BWF with those children with 
SA without BWF in the immediate 6 months after discharge.
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METHODS
Design
This was a prospective cohort study carried out at Jinja Regional 
Referral Hospital (Jinja RRH) in southeastern Uganda. Jinja 
RRH serves a mainly rural population in a region of high ma-
laria transmission between the shores of Lakes Victoria and 
Kyoga [24].
Study Participants
From June 2016 to January 2018, children with SA (Hb ≤5.0 g/
dL) aged 0–5  years presenting to the pediatric ward of Jinja 
RRH were screened for enrollment into the study. Children 
who had been transfused in the previous 4 weeks or who 
presented due to surgical conditions or those with SA due to 
known chronic conditions such as tuberculosis or malignan-
cies were excluded. Children with SA due to sickle cell anemia 
(confirmed by Hb electrophoresis) were also excluded since 
their underlying condition is known to be associated with re-
current readmissions and anemia. During hospitalization, 
enrolled participants were managed according to the routine 
standard of care as per national treatment guidelines [25], 
which included a prompt blood transfusion, investigations to 
establish associated comorbid diagnoses, and treatment of co-
morbid conditions.
Tests and Treatment
Malaria microscopy was performed for all children, and children 
with parasitemia were given parenteral artesunate for at least 24 
hours followed by a full course of artemether-lumefantrine as 
per guidelines [25]. Other tests to establish comorbid diagnoses 
associated with the SA included a blood culture for bacteremia 
if the axillary temperature was greater than 38.0°C; screening for 
the human immunodeficiency virus using a statapak kit STAT-
PAK (Chembio); urine and stool microscopy for schistosomi-
asis and worm infestations, respectively; serum assays for levels 
of ferritin, folate, and vitamin B-12; and complete blood count 
to type the anemia. As per guidelines, blood transfusion was 
given to all children with SA with Hb of 5.0 g/dL or less at a dose 
of 10  mL/kg (packed cells) or 20  mL/kg whole blood. Broad-
spectrum antibiotics were given for suspected bacteremia; hook-
worm infection was treated with oral albendazole. All children 
were put on a 3-month regimen of oral hematinics on discharge.
The diagnosis of BWF was made on clinical grounds. Any child 
with a history of passage of dark-brown, tea-colored urine during 
the present episode of illness observed by the caregiver and, where 
possible, by the study clinician was diagnosed as having BWF. No 
clinical tests were done to confirm the diagnosis. Children with 
BWF were managed symptomatically with blood transfusion and 
treatment of comorbid conditions. Presently, there is no specific 
management of BWF, but all cases are treated as severe malaria 
and the respective supportive treatment such as blood transfusion 
is given as per the Ugandan clinical guidelines [25].
Follow-up and Postdischarge Care
On discharge, all study children were asked to return to the hos-
pital for a follow-up visit in 6 months. A predischarge Hb collec-
tion was done to ensure that the SA was corrected. Caregivers 
were also asked to bring their children back to the study team 
at Jinja RRH whenever the children became sick during the fol-
low-up period. All hospital visits and admissions to Jinja RRH 
were recorded, and children who presented with a history of 
fever or had a high temperature on examination had a malaria 
blood smear and/or rapid diagnostic test performed. At the end 
of the follow-up period, the vital status of study participants was 
noted and any deaths that occurred during the follow-up period 
were recorded.
Primary Outcome
The primary outcome was a composite of readmissions or 
deaths within the immediate 6 months after discharge.
Sample Size
We calculated that a sample size of 279 would give a power of 
over 90% to detect a 25% difference in frequency readmission 
or death between SA with and without BWF with a 95% con-
fidence interval (CI) and an ɑ of 0.05. We assumed a death or 
readmission rate of 12% in the children with SA without BWF 
[11].
Statistical Analysis
Data were entered in FileMaker Pro and exported to Stata ver-
sion 14 for analysis (StataCorp, 2015). Demographic charac-
teristics between the 2 groups were compared using Pearson 
chi-square and Wilcoxon rank sum tests. The frequency and 
incidence of study endpoints (outpatient visits, readmissions, 
or deaths) were determined and compared for children with SA 
with BWF and those without BWF using chi-square and inci-
dent rate ratios, respectively. Hazard ratios (HRs) were calcu-
lated and adjusted for age, sex, nutritional status (weight-for-age 
z scores), and parasitemia using Cox regression.
Ethical Considerations
Ethical approval was granted by the Makerere University School 
of Medicine Research and Ethics Committee and the Uganda 
National Council of Science and Technology. Written informed 
consent was obtained from the caregivers of all the children.
RESULTS
During the study period, 284 children with SA were admitted to 
Jinja RRH, of whom 282 were discharged and were eligible for 
this study (Figure 1). However, 3 children were lost to follow-up 
and at the end of the 6-month follow-up period, data on vital 
status (alive or dead) were available for 279 (98.9%) of the eligible 
children who were included in the analysis (Figure 1). Ninety-
two (32.9%) of the children with SA included in the analysis had 
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BWF (Figure 1). There was no difference in the sex distribution, 
social economic status, and level of predischarge Hb concen-
tration between children with SA with BWF and those without 
BWF (Table 1). At presentation to hospital, children with SA 
with BWF were more likely to be older, jaundiced and have a 
higher concentration of Hb and palpable spleen compared with 
children SA without BWF (all P < .05) (Table 1). However, chil-
dren with SA without BWF were more likely to be stunted than 
children with SA with BWF (Table 1). All children in the study 
received a transfusion at admission but more children with SA 
with BWF required multiple transfusions during admission than 
children without BWF (Table 1). At admission, the prevalence 
of parasitemia and leukocytosis was similar between children 
with and without BWF (Table 1). The prevalence of exposure 
to recent malarial infection (positive rapid diagnostic test) was 
similar between the study groups (Table 1). However, among 
children with parasitemia at admission, children with SA with 
BWF had lower mean parasite density than children with SA 
without BWF (43 826 vs 107 618, respectively; P = .04).
Overall, 14 (5.0%) of children with SA with malaria parasit-
emia had other features of severe malaria such as impaired con-
sciousness or respiratory distress. The proportion of children 
with other features of severe malaria were similar in the study 
groups.
Outpatient Clinic Visits, Readmissions, and Deaths During Follow-up
Overall, 72 (25.8%) of study participants had outpatient clinic 
visits, 128 (45.9%) were readmitted at least once, while 22 
(7.9%) died during the follow-up period. The numbers of chil-
dren who were readmitted or died were significantly higher in 
children with SA with BWF than in those without BWF: 54.4% 
versus 41.7% (P = .046) and 14.1% versus 4.8% (P = .007), re-
spectively (Table 2).
There was a total of 96 clinic visits and 213 readmissions 
during the study period (Table 2). Children with BWF had a 
significantly higher incidence of readmissions and deaths than 
those without BWF: 231.42 versus 116.03 (P < .001) and 29.49 
versus 9.41 (P =  .005), respectively (Table 2). The incidence of 
outpatient visits was also higher in the children with SA with 
BWF, but the difference was not statistically significant (Table 2).
Causes of Readmissions
There were multiple admissions in 52 (40.6%) of the readmissions. 
Children with SA with BWF had more multiple readmissions than 
Figure 1. Study profile of children with severe anemia who were screened and followed up. Abbreviations: BWF, blackwater fever; F/up, follow-up; Hb, hemoglobin; SA, 
severe anemia; SCA, sickle cell anemia.
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those without BWF, with 25 (50%) having more than 1 admission, 
including 8 (16%) children who had at least 4 readmissions during 
the 6-month follow-up period (Table 3). Malaria and a recurrence 
of the SA were the most common reasons for readmissions, ac-
counting for 100 (78.1%) and 47 (36.7%) of the first readmissions 
and 37 (71.2%) and 21 (40.4%) of the second readmissions, re-
spectively (Table 3). Among the children with SA with BWF, a 
repeat episode of BWF occurred in 50–60% of the readmissions, 
while 9 (11.5%) of readmitted children in the no-BWF group re-
ported an episode of BWF at the first readmission (Table 3).






Children with outpatient clinic visits, n (%) 25 (27.2) 47 (25.1) .714
Number of outpatient clinic visits 33 63  
Incidence of outpatient clinic visits, events per 100 person-years 74.87 65.85 .274
Children readmitted, n (%) 50 (54.4) 78 (41.7) .046
Readmissions, no. of events 102 111  
Incidence of readmissions, events per 100 person-years 231.42 116.03 <.001
Deaths, n (%) 13 (14.1) 9 (4.8) .007
Deaths, no. of events 13 9  
All-cause mortality per 100 person-years 29.49 9.41 .005
Abbreviation: BWF, blackwater fever.
Table 1. Demographic and Clinical Characteristics of Children With Severe Anemia With and Without Blackwater Fever Discharged From Jinja Regional 








Demographic characteristics    
 Mean (SD) age, y 2.2 (1.2) 2.8 (1.0) .001
 Sex, n (% male) 119 (63.6) 57 (61.9) .785
 Mean (SD) total SES scorea 12.0 (3.7) 11.5 (3.9) .291
 Mean (SD) postdischarge Hb,b g/dL 7.5 (1.2) 7.6 (1.3) .792
 Mean (SD) duration of hospitalization, d 4.2 (2.1) 4.7 (1.7) .160
Clinical features at presentation    
 Referred, n (%) 112 (59.9) 57 (61.9) .740
 Mean (SD) duration of illness, d 3.9 (1.9) 3.6 (1.7) .226
 Previous history of transfusion, n (%) 49 (26.2) 54 (58.7) <.001
 Mean (SD) axillary temperature, °C 37.4 (0.8) 37.3 (0.8) .340
 Stunted (HAZ < −2 SDs), n/N (%) 57/181 (31.5) 15/90 (16.7) .009
 Mean (SD) admission Hb, g/dL) 3.6 (0.9) 3.8 (0.8) .044
Clinical presentation, n (%)    
 Jaundice 28 (14.9) 34 (36.9) <.001
 Hepatomegaly 43 (22.9) 28 (30.4) .180
 Splenomegaly 99 (52.9) 58 (63.0) .110
Received multiple transfusions, n (%) 71 (37.0) 55 (59.8) .001
Malaria parasitemia, n (%) 69 (36.9)c 35 (38.0) .852
Recent malarial infectiond 95/169 (56.2) 45/83 (54.2) .788
Leukocytosis,e n (%) 55/176 (29.9) 37 (40.2) .086
HIV positive, n (%) 5 (2.7) 1 (1.1) .390
Abbreviations: BWF, blackwater fever; HAZ, height-for-age z score; Hb, hemoglobin; HIV, human immunodeficiency virus; SD, standard deviation; SA, severe anemia; SES, socioeconomic 
status.
aSES score available for 275 patients (BWF = 91, no BWF = 184).
bHb available for 267 participants (BWF = 90, no BWF = 177).
cMalaria parasitemia results available for 91 participants with BWF.
dHad positive malarial rapid diagnostic test but no malaria parasitemia at admission.
eLeukocytosis = white blood cell count >12.0 /µL.
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Timing of Readmission
Overall, 42 of 128 (32.8%) of the readmissions occurred within 
6 weeks of discharge from the hospital, while 79 of 128 (61.7%) 
of the readmissions occurred within 3 months. The timing of 
readmissions was not significantly different when stratified ac-
cording to readmission diagnoses or study groups.
Deaths
The majority (20/22; 90.9%) of the deaths occurred at home 
in the community, most of which were reportedly after an epi-
sode of acute febrile illness. The 2 children who died in the hos-
pital were in the BWF group and in both cases severe malarial 
anemia was the reason for the readmission. In unadjusted anal-
ysis, children with SA with BWF had a statistically significantly 
shorter time to first readmission and death than children in the 
no-BWF group (Figures 2 and 3).
Risk of Readmission and Deaths
After adjusting for age, sex, nutritional status, and parasitemia, chil-
dren with SA with BWF had a significantly higher risk of readmis-
sions (HR, 1.68; 95% CI, 1.1–2.5) and a greater risk of death (HR, 
3.37; 95% CI, 1.3–8.5) compared with those without BWF (Table 
4). However, there was no increased risk of outpatient visits in the 
children with SA with BWF compared with those without BWF.
DISCUSSION
We followed up a cohort of children with SA for 6 months after 
discharge from the hospital. Nearly half (45.9%) the children 
Table 3. Postdischarge Readmissions and Their Causes Among 279 Children With Severe Anemia With and Without Blackwater Fever at Jinja Regional 
Referral Hospital
 
Readmission 1 Readmission 2 Readmission 3 Readmission 4
No BWF BWF No BWF BWF No BWF BWF No BWF BWF
Severe malariaa 64 (82.1) 36 (72.0) 17 (68.0) 20 (74.1) 5 (71.4) 10 (71.4) 1 (100) 6 (75.0)
Severe anemiab 28 (35.9) 19 (38.0) 10 (40.0) 11 (40.7) 3 (42.9) 5 (35.7) 0 (0.0) 4 (50.0)
BWF 9 (11.5) 29 (58.0) 5 (20.0) 16 (59.3) 2 (28.6) 8 (57.1) 0 (0.0) 4 (50.0)
Transfused 36 (46.2) 26 (52.0) 13 (52.0) 16 (59.3) 4 (57.1) 5 (35.7) 0 (0.0) 4 (50.0)
Total,c n 78 50 25 27 7 14 1 8
Data are presented as n (%) unless otherwise noted.
Abbreviation: BWF, blackwater fever.
aAll children with positive blood smear or rapid diagnostic test for malaria.
bSevere anemia (Hb <5.0 g/dL) with or without malaria parasitemia.
cSome patients had more than 1 diagnosis so column totals do not add up to 100%.
Figure 2. Time to readmission to the hospital in the 6-month postdischarge period for children with severe anemia with blackwater fever (BWF) and those without BWF. 
Abbreviation: hemoglobin2_mhx = 0, SA without BWF; hemoglobin2_mhx = 1, SA with BWF; SA, severe anemia.
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with SA were readmitted after discharge, which is much higher 
than postdischarge rates of 9.4% [9] and 17.2% [7] previously 
reported. Disturbingly, there was a high rate of multiple re-
admissions for all children with SA, especially in children with 
SA associated with BWF, where half (50%) had multiple re-
admissions. The overall postdischarge mortality of 7.5% found 
in this study was only slightly lower than the 13% reported in 
Kenyan and Malawian studies, which were conducted at a time 
of increasing malarial resistance to chloroquine [7, 8]. Overall, 
our study found a high burden of postdischarge morbidity in 
children with SA, particularly those with BWF. Children with 
SA with BWF had a 68% increased risk of readmission and 
were more than 3 times more likely to die in the 6-month 
postdischarge period than children with SA without BWF.
The overall rate of readmissions and deaths observed in SA 
children in this study is of public health concern. The readmis-
sion rate of 45.9%, is 4 times higher than 9.4%, which our group 
previously reported for children with severe malarial anemia ad-
mitted at Mulago hospital. Given that there have been no major 
changes in malaria treatment guidelines or admission criteria in 
the country, the likely explanation for disparity in the findings 
is the higher malaria transmission at Jinja RRH [24]. The high 
burden of malaria in this part of the country is associated with 
a correspondingly high burden of SA and BWF. In the Fluid 
Expansion As Supportive Therapy trial [20], the prevalence 
of SA and BWF at sites in eastern Uganda was approximately 
2 times higher than that in Mulago: Soroti (SA, 43%; BWF, 
22%) compared with Mulago (SA, 23%; BWF, 6%). Therefore, 
Table 4. Hazard Ratios for Outpatient Clinic Visits, Postdischarge Readmissions, or Deaths Among 279 Children With Severe Anemia With and Without 
Blackwater Fever at Jinja Regional Referral Hospital
Crude HR (95% CI) P Adjusteda HR (95% CI) P 
Outpatient clinic visits     
 No BWF (n = 187) 1.0 (ref)  …  
 BWF (n = 92) 1.45 (.9, 2.4) .138 1.46 (.9, 2.5) .156
Readmissions     
 No BWF (n = 187) 1.0 (ref)  …  
 BWF (n = 92) 1.73 (1.2, 2.5) .003 1.68 (1.1, 2.5) .008
Deaths     
 No BWF (n = 187) 1.0 (ref)  …  
 BWF (n = 92) 3.20 (1.4, 7.5) .007 3.37 (1.3, 8.5) .010
Abbreviations: BWF, blackwater fever; CI, confidence interval; HR, hazard ratio; ref, reference. 
aAdjusted for age, sex, stunting, and parasitemia.
Figure 3. Time to death in the 6-month postdischarge period for children with severe anemia with blackwater fever (BWF) and those without BWF. Abbreviation: hemo-
globin2_mhx = 0, SA without BWF; hemoglobin2_mhx = 1, SA with BWF; SA, severe anemia.
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exposure of children with SA to repeat malarial attacks at a vul-
nerable period after discharge may be a key driver of the high 
readmission rates observed in this study. It is possible that the 
high burden of SA is compounded by other factors such as un-
derlying poverty/malnutrition in this mainly rural population 
and other underlying genetic factors. Ongoing studies in the 
Jinja area have also noted similar high rates of admissions and 
readmissions. Further studies are therefore needed to establish 
the reasons for the high disease burden in this region. In the 
meantime, efforts are urgently therefore needed to reduce the 
burden of malaria in this population.
For children with BWF, epidemiological studies suggest that 
the interaction between host response to repeated malarial 
attacks, use of antimalarials, and possibly glucose 6 phosphate 
dehydrogenase deficiency are triggers for episodes of BWF [13, 
26]. Blackwater fever is characterized by episodes of repeated 
acute hemolysis requiring hospitalizations for transfusions. In 
this study approximately 60% of children with BWF reported 
a history of transfusions prior to enrollment and a similar per-
centage required multiple transfusions at the time of enrollment 
hospitalization. Recent episodes of BWF in eastern Uganda 
were found to be triggered by the interaction between P. falcip-
arum malaria and increased use of artemisinin derivatives [12]. 
Acute renal failure is thought to be the cause of death in chil-
dren with SA with BWF [22, 26]. We were unable to ascertain 
whether children in this study died of renal failure since most of 
the deaths occurred in the community.
Irrespective of the associated diagnoses, malaria was the 
most common reason for readmission, accounting for more 
than 70% of the diagnoses at readmission. This suggests that, 
for children with SA, efforts should be focused on preventing 
exposure to malaria in the immediate postdischarge period. 
Although, overall, approximately 60% of the readmissions oc-
curred in the first 3 months after discharge, readmissions due 
to malaria were spread over the entire 6-month follow-up pe-
riod. Postdischarge malarial prophylaxis may therefore be 
required for at least 6 months after discharge. Phiri et al [27] 
showed that for children with severe malarial anemia, provi-
sion of malarial chemoprophylaxis in the first 3  months was 
associated with a 31% reduction in morbidity and mortality. 
A larger study is currently underway in Kenya and Uganda to 
determine whether malarial chemoprophylaxis will be effec-
tive and safe in reducing postdischarge mortality in children 
with SA. Another large clinical trial that examined a number of 
treatment strategies, including micronutrient supplements to 
reduce postdischarge morbidities in children with SA, has re-
cently been completed [28]. The strategies included giving lib-
eral amounts of blood transfusion, followed by postdischarge 
cotrimoxazole prophylaxis and or multivitamin-multimineral 
supplementation [28].
It is interesting to note that in our cohort only 2 children 
died in the hospital out of 213 episodes of hospitalizations. The 
majority of the deaths in this study occurred at home before 
the caretakers could bring the children back to the hospital. 
Postdischarge mortality was highest (14.1%) among children 
with SA with BWF, a finding similar to the 28-day mortality of 
12% in children with BWF reported earlier in eastern Uganda 
[12]. Overall, these findings suggest that once the children 
made it to the hospital, they were more likely to be treated and 
to survive. This suggests that the inability to access urgent care 
may have been the underlying factor in postdischarge survival 
of these children.
The study had a number of limitations. During the follow-up 
period, approximately 12% of children with SA who were clas-
sified in the no-BWF group presented with features of BWF 
during the first readmission. It is therefore possible that these 
children developed BWF in the course of the study. Due to the 
paroxysmal nature of the condition, it was not possible to pre-
dict, during admission, which children would later develop fea-
tures of BWF [12]. It is therefore possible that the true burden of 
postdischarge morbidity in children with SA with BWF is even 
higher than what was found in this study.
The study was conducted in only 1 site in eastern Uganda, 
so the findings may be subject to particular genetic and epide-
miological factors unique to that area. For children with BWF, 
we did not perform urine studies to confirm hemoglobinuria 
or test for glucose 6 phosphate dehydrogenase deficiency, 
which is thought to be an important risk factor for BWF [26]. 
Nonetheless, our study was pragmatic and was based on the di-
agnostic capabilities used in routine practice in a low-resource 
setting. This study therefore highlights the burden of and risk 
factors for the postdischarge outcomes for a clinical episode of 
SA in a malaria-endemic setting.
In conclusion, we found that children with SA in Jinja 
RRH have a high frequency of postdischarge readmission and 
death. Children with SA with BWF, in particular, had a poor 
postdischarge outcome, with increased risk of readmission and 
death. There is a need for implementation of postdischarge 
malaria chemoprophylaxis for children with SA in malaria-
endemic areas. Future studies should focus on understanding 
the pathophysiological mechanisms of BWF in children living 
in malaria-endemic areas.
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